Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petra Hirsova

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Cellular and Molecular Gastroenterology and Hepatology|June 11, 2021
Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and BetterPetra Hirsova
Med (New York, N.Y.)|May 19, 2022
Fatty liver progression and carcinogenesis: Beware of pathogenic T cellsPetra Hirsova, Gregory J Gores
Frontiers in Endocrinology|October 10, 2022
Editorial: Immune mechanisms of inflammation in NASHPetra Hirsova, Xavier S Revelo
Cellular and Molecular Gastroenterology and Hepatology|February 18, 2017
ReplyPetra Hirsova, Gregory J Gores
Hepatology (Baltimore, Md.)|July 1, 2014
Ballooned hepatocytes, undead cells, sonic hedgehog, and vitamin E: therapeutic implications for nonalcoholic steatohepatitisPetra Hirsova, Gregory J Gores
Cellular and Molecular Gastroenterology and Hepatology|March 3, 2015
Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic SteatohepatitisPetra Hirsova, Gregory J Gores
Gut|January 26, 2018
Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammationSamar H Ibrahim, Petra Hirsova, Gregory J Gores
Hepatology (Baltimore, Md.)|May 19, 2017
Proapoptotic signaling induced by deletion of receptor-interacting kinase 1 and TNF receptor-associated factor 2 results in liver carcinogenesisPetra Hirsova, Maria Eugenia Guicciardi, Gregory J Gores
Biology|November 17, 2020
Emerging Roles of Liver Sinusoidal Endothelial Cells in Nonalcoholic SteatohepatitisKunimaro Furuta, Qianqian Guo, Petra Hirsova, et al.
Hepatology (Baltimore, Md.)|August 6, 2024
Do autoantigens drive MASH progression?Lucía Valenzuela-Pérez, Hyun Se Kim Lee, Petra Hirsova
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Cellular and Molecular Gastroenterology and Hepatology|June 11, 2021
Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and BetterPetra Hirsova
Med (New York, N.Y.)|May 19, 2022
Fatty liver progression and carcinogenesis: Beware of pathogenic T cellsPetra Hirsova, Gregory J Gores
Frontiers in Endocrinology|October 10, 2022
Editorial: Immune mechanisms of inflammation in NASHPetra Hirsova, Xavier S Revelo
Cellular and Molecular Gastroenterology and Hepatology|February 18, 2017
ReplyPetra Hirsova, Gregory J Gores
Hepatology (Baltimore, Md.)|July 1, 2014
Ballooned hepatocytes, undead cells, sonic hedgehog, and vitamin E: therapeutic implications for nonalcoholic steatohepatitisPetra Hirsova, Gregory J Gores
Cellular and Molecular Gastroenterology and Hepatology|March 3, 2015
Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic SteatohepatitisPetra Hirsova, Gregory J Gores
Gut|January 26, 2018
Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammationSamar H Ibrahim, Petra Hirsova, Gregory J Gores
Hepatology (Baltimore, Md.)|May 19, 2017
Proapoptotic signaling induced by deletion of receptor-interacting kinase 1 and TNF receptor-associated factor 2 results in liver carcinogenesisPetra Hirsova, Maria Eugenia Guicciardi, Gregory J Gores
Biology|November 17, 2020
Emerging Roles of Liver Sinusoidal Endothelial Cells in Nonalcoholic SteatohepatitisKunimaro Furuta, Qianqian Guo, Petra Hirsova, et al.
Hepatology (Baltimore, Md.)|August 6, 2024
Do autoantigens drive MASH progression?Lucía Valenzuela-Pérez, Hyun Se Kim Lee, Petra Hirsova
Pageof 9